Loading...

Double-blind, prospective, multicenter trial comparing ceftazidime with moxalactam in the treatment of serious gram-negative infections.

Ceftazidime is a new antimicrobial agent possessing excellent in vitro activity against most members of the family Enterobacteriaceae and against Pseudomonas aeruginosa. We conducted a double-blind, prospective, multicenter trial to compare ceftazidime with moxalactam in the treatment of serious gra...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Joshi, M, Anthony, W C, Tenney, J H, Drusano, G L, Caplan, E S, Standiford, H C, Henson, A, Warren, J W
Format: Artigo
Sprog:Inglês
Udgivet: 1986
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC176442/
https://ncbi.nlm.nih.gov/pubmed/3530128
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!